Cataracts in setting of multisystem inflammation after COVID-19 vaccination

PURPOSE: To describe a unique case of bilateral cataract formation in the setting of multisystem inflammation after the 1st dose of the BNT162b2 mRNA COVID-19 vaccination. OBSERVATIONS: A previously healthy 20-year-old male developed intumescent bilateral cataracts leading to visual decline from 20/...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Diana H., Hsu, David, Li, Yafeng, Sulewski, Michael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259510/
https://www.ncbi.nlm.nih.gov/pubmed/35818371
http://dx.doi.org/10.1016/j.ajoc.2022.101654
Descripción
Sumario:PURPOSE: To describe a unique case of bilateral cataract formation in the setting of multisystem inflammation after the 1st dose of the BNT162b2 mRNA COVID-19 vaccination. OBSERVATIONS: A previously healthy 20-year-old male developed intumescent bilateral cataracts leading to visual decline from 20/20 to 20/300–20/400 in each eye, likely from systemic inflammation after vaccination. CONCLUSION AND IMPORTANCE: This is the first reported case of cataract formation following a COVID-19 vaccine. While ocular adverse effects associated with COVID-19 vaccination are rare, it is important to raise awareness of these entities amongst medical providers as the COVID-19 pandemic continues and vaccinations become widespread.

Ejemplares similares